MedTrace Logo

Human Urine Sample Collection for Alport Nephropathy Biomarker Studies

NCT01602835 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2014-02-11

No results posted yet for this study

Summary

This is a prospective cross-sectional, observational, single-center study of Alport patients, in which a single, first morning voided urine collection will be acquired and used to validate assays of urine biomarkers that reflect changes in glomerular protein filtration barrier function.

The purpose of this study is to identify biomarkers indicative of changes in glomerular filtration function that occur during the course of proteinuric renal diseases such as Alport nephropathy.

Conditions

  • Alport Syndrome

Sponsors & Collaborators

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2013-05-31
Completion
2013-05-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01602835 on ClinicalTrials.gov